Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Matsui

Showing results (241-250 of 245) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 245 results.
Nature Communications|July 25, 2018
A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancerTomoko Saito, Atsushi Niida, Ryutaro Uchi, et al.
Elife|November 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, et al.
JCI Insight|May 17, 2022
Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccinationYusuke Matsui, Lin Li, Mary Prahl, et al.
Science Advances|April 23, 2025
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M<sup>Pro</sup> inhibitors with potent in vivo efficacyTyler C Detomasi, Gilles Degotte, Sijie Huang, et al.
Nature|August 28, 2024
Fibrin drives thromboinflammation and neuropathology in COVID-19Jae Kyu Ryu, Zhaoqi Yan, Mauricio Montano, et al.
Pageof 25

Showing results (241-250 of 245) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
Nature Communications|July 25, 2018
A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancerTomoko Saito, Atsushi Niida, Ryutaro Uchi, et al.
Elife|November 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, et al.
JCI Insight|May 17, 2022
Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccinationYusuke Matsui, Lin Li, Mary Prahl, et al.
Science Advances|April 23, 2025
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M<sup>Pro</sup> inhibitors with potent in vivo efficacyTyler C Detomasi, Gilles Degotte, Sijie Huang, et al.
Nature|August 28, 2024
Fibrin drives thromboinflammation and neuropathology in COVID-19Jae Kyu Ryu, Zhaoqi Yan, Mauricio Montano, et al.
Pageof 25